Zhejiang Huakang Pharmaceutical Co Ltd (605077) - Total Liabilities

Latest as of June 2025: CN¥4.32 Billion CNY ≈ $632.34 Million USD

Based on the latest financial reports, Zhejiang Huakang Pharmaceutical Co Ltd (605077) has total liabilities worth CN¥4.32 Billion CNY (≈ $632.34 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Zhejiang Huakang Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.

Zhejiang Huakang Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Zhejiang Huakang Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Zhejiang Huakang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Huakang Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Sichuan Discovery Dream Science & Technology Co.Ltd
SHE:301213
China CN¥164.53 Million
Bumi Serpong Damai Tbk
JK:BSDE
Indonesia Rp25.91 Trillion
Africa Oil Corp
TO:AOI
Canada CA$1.59 Billion
Synsam AB
ST:SYNSAM
Sweden Skr5.83 Billion
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
USA $322.93 Million
EnTie Commercial Bank Ltd
TW:2849
Taiwan NT$352.10 Billion
Jaya Real Property Tbk
JK:JRPT
Indonesia Rp4.11 Trillion
Gujarat Ambuja Exports Limited
NSE:GAEL
India Rs6.81 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 605077 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.65 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.34 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Huakang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Huakang Pharmaceutical Co Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥3.74 Billion
≈ $546.80 Million
+21.45%
2023-12-31 CN¥3.08 Billion
≈ $450.21 Million
+146.29%
2022-12-31 CN¥1.25 Billion
≈ $182.80 Million
+119.33%
2021-12-31 CN¥569.56 Million
≈ $83.34 Million
+16.20%
2020-12-31 CN¥490.16 Million
≈ $71.73 Million
+4.47%
2019-12-31 CN¥469.20 Million
≈ $68.66 Million
-22.73%
2018-12-31 CN¥607.22 Million
≈ $88.86 Million
+18.10%
2017-12-31 CN¥514.17 Million
≈ $75.24 Million
-5.83%
2016-12-31 CN¥546.03 Million
≈ $79.90 Million
--

About Zhejiang Huakang Pharmaceutical Co Ltd

SHG:605077 China Chemicals
Market Cap
$820.40 Million
CN¥5.61 Billion CNY
Market Cap Rank
#10092 Global
#2844 in China
Share Price
CN¥18.50
Change (1 day)
+3.29%
52-Week Range
CN¥14.00 - CN¥19.78
All Time High
CN¥42.31
About

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltito… Read more